IMMUNIC Faces Nasdaq Delisting Over Bid Price
Ticker: IMUX · Form: 8-K · Filed: Jun 27, 2025 · CIK: 1280776
| Field | Detail |
|---|---|
| Company | Immunic, INC. (IMUX) |
| Form Type | 8-K |
| Filed Date | Jun 27, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, compliance, stock-price
Related Tickers: NDAQ
TL;DR
Nasdaq says IMMUNIC's stock is too cheap, giving them until Dec 23 to fix it or get booted.
AI Summary
On June 27, 2025, IMMUNIC, INC. filed an 8-K report indicating a potential delisting from the Nasdaq Capital Market. The company received a deficiency letter from Nasdaq on June 26, 2025, stating it no longer meets the minimum bid price requirement of $1.00 per share. IMMUNIC has 180 calendar days, until December 23, 2025, to regain compliance.
Why It Matters
Failure to meet Nasdaq's minimum bid price requirement could lead to delisting, impacting the stock's liquidity and investor confidence.
Risk Assessment
Risk Level: high — The company is at high risk of delisting from a major stock exchange if it cannot meet the minimum bid price requirement.
Key Numbers
- $1.00 — Minimum Bid Price (The minimum price per share required by Nasdaq to remain listed.)
- 180 days — Compliance Period (The timeframe IMMUNIC has to meet the minimum bid price requirement.)
Key Players & Entities
- IMMUNIC, INC. (company) — Registrant
- Nasdaq Capital Market (company) — Exchange where IMMUNIC is listed
- June 27, 2025 (date) — Date of 8-K filing
- June 26, 2025 (date) — Date of Nasdaq deficiency letter
- December 23, 2025 (date) — Deadline for IMMUNIC to regain compliance
- $1.00 (dollar_amount) — Minimum bid price requirement
FAQ
What is the primary reason for IMMUNIC's potential delisting?
IMMUNIC received a deficiency letter from Nasdaq stating it no longer meets the minimum bid price requirement of $1.00 per share.
What is the deadline for IMMUNIC to regain compliance with Nasdaq's listing rules?
The company has 180 calendar days from the notice, which is until December 23, 2025, to regain compliance.
Which stock exchange is threatening to delist IMMUNIC?
The Nasdaq Capital Market is the exchange that has notified IMMUNIC of its non-compliance with the minimum bid price rule.
What specific rule is IMMUNIC failing to meet?
IMMUNIC is failing to meet the continued listing rule regarding the minimum bid price of its common stock, which must be at least $1.00 per share.
What action has IMMUNIC taken as a result of the deficiency letter?
IMMUNIC has filed a Form 8-K to report the receipt of the deficiency letter from Nasdaq and to inform the public of the situation.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 27, 2025 regarding IMMUNIC, INC. (IMUX).